Upadacitinib and Pain in RA, PsA - Top_Thought_Leaders - MDSpire

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

  • By

  • Kathryn Wighton

  • February 25, 2026

  • 4 min

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

Upadacitinib and Pain in RA, PsA

  • by Kathryn Wighton

  • February 25, 2026

Related Content

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

Health Resorts as an integrated community healthcare model for fibromyalgia syndrome: a strategic SWOT analysis

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.